Blog
NETRF Announces $2.5 Million in Research to Advance the NETs
New grants to explore CAR-T, PRRT, a vaccine for NETs and other innovative approaches.
February 1, 2019
No Comments
Category: For Researchers
About NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Blog
NETRF Researchers Named as World’s Most Influential Scientists for 2018
Clarivate Analytics has released the most influential researcher list for 2018, which identifies exceptional researchers whose highly cited work is among the top 1% in their field around the world.
November 29, 2018
No Comments
Blog
Tb-161: Novel Radionuclide to be Tested
Early Research on Targeting Single Cancer Cells to Prevent Metastasis Despite the effectiveness of Peptide Receptor Radionuclide Therapy (PRRT) to prolong survival of those with
October 16, 2018
3 Comments
Blog
New Grant Explores Novel Drug Delivery System
Antibody-drug conjugate aims to combine the benefits of targeted therapy and chemotherapy Renata Jaskula-Sztul, PhD, Assistant Professor of Surgical Oncology at the University of Alabama
October 15, 2018
2 Comments
For Researchers
Immunotherapy Update: What We’ve Learned
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear
September 27, 2018
No Comments
Blog
Immunotherapy Update: What We’ve Learned
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear
September 11, 2018
1 Comment
Blog
Study to Look for Predictive Biomarker
New Potential NET Treatment under Investigation It is hard for doctors to know which patients will respond to which therapies. New approaches in personalized medicine
August 9, 2018
No Comments
Blog
New Grant Explores Novel Drug Delivery System
Antibody-drug conjugate aims to combine the benefits of targeted therapy and chemotherapy Renata Jaskula-Sztul, PhD, Assistant Professor of Surgical Oncology at the University of Alabama
July 10, 2018
No Comments
Blog
NET Patients: Are you Scheduled for Surgery?
If you are having surgery for a NET tumor, consider donating some of your tumor tissue to help research. The Neuroendocrine Tumor Research Foundation is
July 10, 2018
No Comments
Blog
NETRF Works to Take PRRT to Next Level
The Neuroendocrine Tumor Research Foundation (NETRF) has invested more than $1.5 million in advancing a precision form of radiation therapy for NETs called Peptide Receptor
July 10, 2018
2 Comments